American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
MarketAxess Holdings
MKTX
|
+$259M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Duke Energy
DUK
|
+$192M |
| 4 |
Colgate-Palmolive
CL
|
+$187M |
| 5 |
Labcorp
LH
|
+$168M |
Top Sells
| 1 |
Emerson Electric
EMR
|
+$252M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$246M |
| 3 |
Quest Diagnostics
DGX
|
+$218M |
| 4 |
Aflac
AFL
|
+$149M |
| 5 |
nVent Electric
NVT
|
+$129M |
Sector Composition
| 1 | Technology | 19.47% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 15.07% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Industrials | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Neurocrine Biosciences
NBIX
$14.3B
| $96.2M | 0.08% |
805,500
-238,010
| -23% | -$28.4M |
|
277
Bank of America
BAC
$372B
| $96M | 0.08% |
2,897,508
-620,149
| -18% | -$20.5M |
|
278
Tractor Supply
TSCO
$31.3B
| $95.9M | 0.08% |
2,131,180
-72,950
| -3% | -$3.28M |
|
279
Parker-Hannifin
PH
$95.7B
| $95.2M | 0.08% |
327,152
+7,433
| +2% | +$2.16M |
|
280
Ameris Bancorp
ABCB
$5.05B
| $95.2M | 0.08% |
2,018,947
-314,970
| -13% | -$14.8M |
|
281
Uber
UBER
$199B
| $94.6M | 0.08% |
3,823,469
+569,179
| +17% | +$14.1M |
|
282
Broadcom
AVGO
$1.58T
| $94.5M | 0.08% |
1,689,330
-151,720
| -8% | -$8.48M |
|
283
Zebra Technologies
ZBRA
$15.9B
| $94.4M | 0.08% |
368,185
+887
| +0.2% | +$227K |
|
284
ICICI Bank
IBN
$114B
| $93.2M | 0.08% |
4,255,971
-59,833
| -1% | -$1.31M |
|
285
Enphase Energy
ENPH
$4.96B
| $92.1M | 0.08% |
347,523
-39,336
| -10% | -$10.4M |
|
286
EPAM Systems
EPAM
$9.19B
| $90.7M | 0.07% |
276,680
-29,204
| -10% | -$9.57M |
|
287
Dentsply Sirona
XRAY
$2.77B
| $89.3M | 0.07% |
2,806,196
+118,885
| +4% | +$3.79M |
|
288
McKesson
MCK
$87.8B
| $89.3M | 0.07% |
238,167
-83,678
| -26% | -$31.4M |
|
289
Archer Daniels Midland
ADM
$29.9B
| $89.3M | 0.07% |
961,808
+548,973
| +133% | +$51M |
|
290
Intercontinental Exchange
ICE
$99.3B
| $89.2M | 0.07% |
869,134
+55,270
| +7% | +$5.67M |
|
291
Amgen
AMGN
$151B
| $88.6M | 0.07% |
337,205
-41,671
| -11% | -$10.9M |
|
292
Sarepta Therapeutics
SRPT
$1.85B
| $88.5M | 0.07% |
682,662
-284,035
| -29% | -$36.8M |
|
293
Okta
OKTA
$16.5B
| $88.3M | 0.07% |
1,291,666
-304,989
| -19% | -$20.8M |
|
294
Phillips 66
PSX
$53.5B
| $87.9M | 0.07% |
844,231
-222,261
| -21% | -$23.1M |
|
295
Bankunited
BKU
$2.89B
| $86.5M | 0.07% |
2,545,497
-228,422
| -8% | -$7.76M |
|
296
Arthur J. Gallagher & Co
AJG
$76.7B
| $86.1M | 0.07% |
456,737
+389,914
| +584% | +$73.5M |
|
|
GMS
297
DELISTED
GMS Inc
GMS
| $85.8M | 0.07% |
1,722,249
+31,458
| +2% | +$1.57M |
|
298
EQT Corp
EQT
$31.4B
| $85.1M | 0.07% |
2,514,087
+844,619
| +51% | +$28.6M |
|
299
American Century Multisector Income ETF
MUSI
$175M
| $84.4M | 0.07% |
1,973,189
| – | – |
|
300
Berkshire Hathaway Class A
BRK.A
$1.06T
| $84.4M | 0.07% |
180
| – | – |
|